Glomerulonephritis

Glomerulonephritis is an inflammatory condition affecting the glomeruli, which are the tiny filtering units within a cat's kidneys responsible for removing waste products from the blood while retaining essential proteins and cells. This kidney disease occurs when the glomeruli become damaged and inflamed, typically due to immune-mediated processes where the body's own immune system deposits antibody complexes within these delicate structures. Glomerulonephritis represents one of the significant causes of chronic kidney disease in cats and can lead to progressive loss of kidney function if left untreated or poorly managed. While not as commonly diagnosed as some other feline kidney conditions, glomerulonephritis affects cats of various ages, though middle-aged to older cats appear to be more frequently affected.

The underlying cause of glomerulonephritis in cats is most often related to immune complex deposition within the glomerular basement membrane. These immune complexes form when the body produces antibodies in response to various antigens, including those associated with chronic infections, inflammatory diseases, or neoplastic conditions. When these antigen-antibody complexes become trapped in the glomeruli, they trigger an inflammatory response that damages the filtration barrier, leading to the characteristic protein loss seen in affected cats. Common underlying conditions associated with feline glomerulonephritis include feline infectious peritonitis, feline leukemia virus infection, feline immunodeficiency virus, chronic bacterial infections, and various forms of cancer.

The impact of glomerulonephritis on a cat's health can be substantial and far-reaching. As the glomeruli become increasingly damaged, their ability to function as effective filters diminishes, resulting in the loss of vital proteins into the urine while simultaneously allowing waste products to accumulate in the bloodstream. This protein loss, particularly the loss of albumin, can lead to secondary complications including fluid accumulation in body cavities, muscle wasting, and impaired immune function. Additionally, the progressive nature of glomerular damage often leads to the development of chronic kidney disease, high blood pressure, and potential blood clotting abnormalities that can affect multiple organ systems.

Glomerulonephritis in cats is considered a treatable but typically not curable condition, with management focusing on addressing underlying causes, reducing protein loss, controlling inflammation, and preserving remaining kidney function. Early detection through routine health screenings and urinalysis significantly improves outcomes, as intervention before extensive glomerular damage occurs offers the best opportunity for slowing disease progression. Cat owners should be aware that this condition often develops silently, with cats showing few obvious signs until significant kidney damage has occurred, emphasizing the importance of regular veterinary examinations and laboratory monitoring for at-risk individuals.

The primary cause of glomerulonephritis in cats is immune complex deposition within the glomerular structures of the kidneys. This occurs when circulating antigen-antibody complexes become trapped in the glomerular basement membrane, triggering an inflammatory cascade that damages the filtration apparatus. The source of these immune complexes varies widely and is often linked to chronic infectious, inflammatory, or neoplastic conditions that stimulate ongoing antibody production. In many cases, the immune response that leads to glomerulonephritis is the body's attempt to fight off an underlying disease, making identification and treatment of the primary condition essential for managing the kidney damage. The most common infectious causes include feline infectious peritonitis virus, feline leukemia virus, and feline immunodeficiency virus, all of which can trigger sustained immune responses.

Genetic and hereditary factors do not appear to play a significant direct role in the development of glomerulonephritis in cats, unlike some other kidney conditions such as polycystic kidney disease. However, certain genetic factors may influence a cat's immune system function and their susceptibility to the infectious or inflammatory conditions that can trigger glomerulonephritis. Some cats may have inherited tendencies toward more robust or dysregulated immune responses, potentially predisposing them to immune-mediated conditions. While specific breed predispositions for glomerulonephritis itself have not been definitively established, breeds prone to certain infectious diseases or immune-mediated conditions may indirectly face higher risks of developing secondary glomerular disease.

Environmental and lifestyle factors can contribute to the development of glomerulonephritis primarily through their influence on exposure to infectious agents and inflammatory conditions. Cats with outdoor access face increased risk of exposure to feline leukemia virus, feline immunodeficiency virus, and various bacterial and parasitic infections that can trigger immune complex formation. Multi-cat households may also present higher transmission risks for infectious diseases. Chronic stress, poor nutrition, and inadequate preventive healthcare can compromise immune function and increase susceptibility to the infections and conditions that underlie many cases of glomerulonephritis. Environmental toxins and certain medications may also contribute to kidney inflammation in some cases.

Several risk factors increase a cat's likelihood of developing glomerulonephritis. Age is a significant factor, with middle-aged to older cats being more commonly affected, likely due to cumulative exposure to infectious agents and the natural decline in immune regulation that occurs with aging. Cats with chronic infections of any kind, including dental disease, skin infections, or systemic illnesses, face elevated risk due to ongoing antigen stimulation. Cats with cancer, particularly lymphoma and other malignancies, may develop glomerulonephritis as a paraneoplastic syndrome. Additionally, cats with other immune-mediated conditions such as inflammatory bowel disease or systemic lupus erythematosus may be predisposed to concurrent glomerular involvement.

The mechanism by which glomerulonephritis develops involves a complex interplay between the immune system and kidney structures. When antigens from infections, tumors, or other sources enter the bloodstream, the immune system produces antibodies that bind to these antigens, forming immune complexes. These complexes normally circulate and are cleared by the body, but when produced in excess or when clearance mechanisms are impaired, they deposit within the glomerular capillary walls. Once deposited, these immune complexes activate the complement system and attract inflammatory cells, leading to local tissue damage. The resulting inflammation disrupts the glomerular basement membrane's integrity, allowing proteins that would normally be retained to leak into the urine while impairing the kidney's ability to filter waste products effectively.

Early warning signs of glomerulonephritis in cats are often subtle and easily overlooked, as cats are masters at hiding illness until disease has progressed significantly. Initial changes may include slightly increased thirst and urination, which owners might attribute to normal variation or aging. Some cats may show mild lethargy or a subtle decrease in activity levels that develops gradually over weeks to months. Appetite may fluctuate, with some cats becoming slightly pickier about food without showing obvious signs of illness. Weight loss often begins slowly and may not be apparent until the cat has lost a significant percentage of body weight. The insidious nature of these early symptoms means that glomerulonephritis is frequently not detected until routine laboratory work reveals protein in the urine or elevated kidney values.

The most common symptoms of established glomerulonephritis relate to protein loss and developing kidney dysfunction. Proteinuria, or protein in the urine, is the hallmark finding, though this is detected through laboratory testing rather than observed directly by owners. As protein loss continues, cats may develop muscle wasting, particularly noticeable along the spine and hindquarters, as the body breaks down muscle tissue to compensate for protein losses. Some cats develop fluid accumulation in the abdomen (ascites) or under the skin (peripheral edema) due to decreased blood protein levels. Increased thirst and urination become more pronounced as kidney function declines, and owners may notice larger clumps in the litter box or more frequent trips to the water bowl.

Behavioral changes associated with glomerulonephritis often reflect the cat's declining health status and discomfort. Affected cats typically become less active, spending more time sleeping and showing reduced interest in play or interaction. Appetite changes are common, with many cats eating less or becoming more selective about food, while some may develop nausea and occasional vomiting. Litter box habits may change, with increased urination frequency or volume, and some cats may begin having accidents outside the litter box due to increased urgency. Social behavior often shifts, with previously friendly cats becoming more withdrawn or irritable, while some cats may seek more attention and comfort from their owners as they feel unwell.

Physical signs of glomerulonephritis that owners or veterinarians may observe include progressive weight loss and muscle wasting, giving the cat a bony or angular appearance. The coat quality often deteriorates, becoming dull, dry, or unkempt as the cat may groom less frequently. Abdominal distension may be visible if ascites develops from significant protein loss. Some cats develop swelling in the limbs or face due to fluid accumulation. Pale gums may indicate anemia, which can develop secondary to chronic kidney disease. Bad breath with a distinctive chemical odor may develop as waste products accumulate in the bloodstream, and some cats may develop mouth ulcers in advanced cases.

Symptom progression in glomerulonephritis typically follows a gradual course over weeks to months, though acute flares can occur. Initially, proteinuria may be the only abnormality, detected incidentally on routine urinalysis. As protein loss continues and kidney damage progresses, clinical signs become more apparent. Cats may transition from mild symptoms to more obvious illness relatively quickly once a critical threshold of kidney function is lost. The severity and rate of progression depend on the underlying cause, the degree of glomerular damage, and whether appropriate treatment is initiated. Some cats experience periods of relative stability interspersed with episodes of worsening, while others show steady decline without intervention.

Emergency symptoms requiring immediate veterinary attention include sudden onset of weakness or collapse, which may indicate blood clot formation (thromboembolism), a serious complication of glomerulonephritis. Severe breathing difficulty or open-mouth breathing may indicate fluid accumulation in the chest cavity. Complete loss of appetite for more than 24 to 48 hours, persistent vomiting, or inability to keep water down requires urgent evaluation. Sudden paralysis or severe pain in the hind legs suggests arterial thromboembolism and constitutes a medical emergency. Any rapid deterioration in condition, including extreme lethargy, seizures, or loss of consciousness, warrants immediate emergency veterinary care, as these may indicate severe electrolyte imbalances or uremic crisis.

The initial veterinary examination for suspected glomerulonephritis begins with a comprehensive physical assessment and detailed history taking. The veterinarian will ask about changes in drinking and urination habits, appetite, activity levels, weight changes, and any previous health problems or diagnoses. Physical examination focuses on assessing body condition, checking for fluid accumulation in the abdomen or limbs, evaluating hydration status, and palpating the kidneys when possible. Blood pressure measurement is an essential component of the examination, as hypertension commonly accompanies glomerular disease. The veterinarian will also look for signs of underlying conditions that might be causing the glomerulonephritis, including checking for enlarged lymph nodes, abdominal masses, or signs of infectious disease.

Diagnostic testing for glomerulonephritis involves several key laboratory analyses. Complete blood count may reveal anemia or changes in white blood cell counts that suggest underlying infection or inflammation. Serum biochemistry panel evaluates kidney function through blood urea nitrogen and creatinine levels, and also assesses protein levels including albumin and globulins. Urinalysis is critical and typically reveals proteinuria (protein in the urine) with relatively inactive sediment, meaning few cells or casts. The urine protein-to-creatinine ratio (UPC) quantifies the degree of protein loss and helps monitor response to treatment. Testing for underlying causes includes screening for feline leukemia virus, feline immunodeficiency virus, and other infectious diseases. Abdominal ultrasound evaluates kidney size, shape, and architecture, and may reveal changes consistent with glomerular disease or identify other abnormalities.

Differential diagnosis is crucial because several conditions can cause similar clinical presentations and laboratory findings. Other forms of kidney disease, including chronic interstitial nephritis and acute kidney injury, must be distinguished from glomerulonephritis. Amyloidosis, a condition where abnormal protein deposits in the kidneys, can cause similar protein loss. Tubular proteinuria, where protein loss originates from the kidney tubules rather than glomeruli, requires different management approaches. Urinary tract infections can cause protein in the urine and must be ruled out. Lower urinary tract conditions and other causes of increased drinking and urination, such as diabetes mellitus or hyperthyroidism, should also be considered. Accurate differentiation between these conditions guides appropriate treatment selection.

Definitive diagnosis of glomerulonephritis ideally requires kidney biopsy with histopathological examination, though this invasive procedure is not always performed in clinical practice. Biopsy allows direct visualization of glomerular changes and can differentiate between various types of glomerular disease, including membranous glomerulonephritis, membranoproliferative glomerulonephritis, and glomerulosclerosis. However, due to the risks associated with kidney biopsy and the general management approach being similar regardless of specific type, many veterinarians make a presumptive diagnosis based on clinical findings, laboratory results, and exclusion of other conditions. When biopsy is performed, it provides valuable prognostic information and may guide more targeted therapy. Results from all diagnostic tests typically require several days to return, and the veterinarian will schedule a follow-up appointment to discuss findings and treatment options once a complete picture of the cat's condition is available.

Initial treatment for glomerulonephritis focuses on stabilizing the patient and addressing any immediate complications that may have developed. Cats presenting with severe protein loss and fluid accumulation may require hospitalization for intravenous fluid therapy to correct dehydration and electrolyte imbalances while carefully avoiding fluid overload. If hypertension is present, blood pressure-lowering medications may be started immediately to prevent further kidney damage and reduce the risk of complications such as retinal detachment or stroke. Cats with severe anemia may require blood transfusions to stabilize their condition before long-term management can begin. The initial treatment phase also involves beginning the diagnostic workup to identify underlying causes that may be triggering the immune response responsible for glomerular damage.

Medical management of glomerulonephritis centers on several key medication categories. Angiotensin-converting enzyme (ACE) inhibitors, such as benazepril or enalapril, are cornerstone therapies that reduce protein loss by decreasing pressure within the glomeruli and have additional protective effects on kidney tissue. These medications are typically continued long-term and doses may be adjusted based on response. Immunosuppressive therapy may be considered in some cases to reduce the immune-mediated inflammation damaging the glomeruli, with medications such as mycophenolate or cyclosporine being options in refractory cases. Aspirin or clopidogrel may be prescribed at low doses to reduce the risk of blood clot formation, a significant complication of protein-losing kidney disease. Additional medications to manage blood pressure, phosphorus levels, and other complications are added as needed based on disease progression.

Surgical intervention is not typically part of glomerulonephritis treatment, as this is a medical rather than surgical condition. However, if an underlying cause requiring surgical intervention is identified, such as a tumor or abscess serving as the source of antigens triggering the immune response, surgical removal may be recommended as part of comprehensive treatment. Kidney transplantation is occasionally performed at specialized veterinary centers for cats with end-stage kidney disease, though this is not common and requires finding a suitable donor and committing to lifelong immunosuppressive therapy. Most cats with glomerulonephritis are managed medically without surgical intervention, with treatment focusing on slowing disease progression and maintaining quality of life.

Supportive care plays a vital role in managing cats with glomerulonephritis and improving their quality of life. Nutritional support includes feeding a high-quality, moderately protein-restricted diet specifically formulated for kidney disease, which helps reduce the workload on damaged kidneys while still providing adequate nutrition. Subcutaneous fluid administration at home may be recommended for cats with chronic dehydration to help maintain hydration and flush toxins. Anti-nausea medications help maintain appetite in cats experiencing uremic nausea. Phosphate binders may be added to food to reduce phosphorus absorption and slow kidney disease progression. Pain management and environmental modifications ensure the cat remains comfortable throughout treatment.

Alternative and complementary treatments may serve as adjuncts to conventional therapy in some cases. Omega-3 fatty acid supplementation, particularly from fish oil sources, may help reduce inflammation and provide some kidney-protective effects. Some veterinarians recommend antioxidant supplements to combat oxidative stress associated with kidney disease. Acupuncture has been used in some cats to help manage nausea, improve appetite, and potentially support overall wellbeing, though evidence for its efficacy specifically in glomerulonephritis is limited. Herbal therapies should be approached with caution, as many can be harmful to cats or interact with prescribed medications. Any complementary treatments should only be used in conjunction with, not instead of, conventional veterinary care and should be discussed with the veterinarian first.

Treatment decisions are influenced by multiple factors including the severity of disease at diagnosis, identified underlying causes, the cat's overall health status, and practical considerations. The underlying cause significantly impacts prognosis and treatment approach; for example, glomerulonephritis secondary to treatable infection has a better outlook than that caused by incurable cancer. Cost considerations are important, as long-term management requires ongoing medications, special diets, and regular monitoring, which can accumulate significant expense over time. The cat's tolerance of medications and the owner's ability to administer treatments at home also influence the treatment plan. Quality of life must be balanced against treatment intensity, with veterinarians helping owners understand expected outcomes and make informed decisions about their cat's care.

The recovery timeline for cats with glomerulonephritis varies significantly depending on the underlying cause, disease severity at diagnosis, and response to treatment. Unlike acute conditions with defined recovery periods, glomerulonephritis is typically a chronic condition requiring long-term management rather than true recovery. Initial response to treatment, particularly reduction in proteinuria, may be observed within two to four weeks of starting therapy, though optimal control often takes several months to achieve. Cats with identifiable and treatable underlying causes may show improvement once the primary condition is addressed, while those with idiopathic disease or incurable underlying conditions face ongoing management. The first three to six months of treatment are particularly important for establishing effective disease control and determining long-term prognosis.

Post-treatment care for cats with glomerulonephritis requires consistent, long-term commitment from owners. Daily medication administration is typically necessary, with most cats requiring ACE inhibitors and potentially additional medications indefinitely. Feeding a prescribed kidney diet and ensuring adequate water intake become permanent lifestyle changes. Subcutaneous fluid administration at home may be recommended for some cats, requiring owners to learn proper technique. Activity restrictions are generally not necessary for cats with stable disease, though avoiding excessive stress is beneficial. Owners should monitor their cat's appetite, weight, urination habits, and overall demeanor daily, keeping records to share with the veterinarian. Regular follow-up appointments, typically every three to six months for stable patients, include blood work and urinalysis to monitor disease progression and treatment efficacy.

Prognosis for cats with glomerulonephritis depends on several factors that should be discussed honestly with the veterinary team. The degree of proteinuria at diagnosis and response to antiproteinuric therapy significantly influence outcomes, with cats achieving good protein control having better long-term survival. The presence and treatability of underlying causes affect prognosis substantially; cats with curable infections may have near-normal life expectancy if kidney damage is not too advanced, while those with underlying cancer face more guarded prognoses. The level of kidney function at diagnosis, indicated by blood work values, provides important prognostic information. Cats diagnosed early with minimal kidney function loss have better outcomes than those with advanced chronic kidney disease. Development of complications such as severe hypertension or thromboembolism worsens prognosis considerably.

Long-term outlook for cats living with glomerulonephritis requires setting realistic expectations while maintaining hope for quality time together. Many cats live months to years with appropriate management, maintaining good quality of life throughout much of this period. The condition is progressive in most cases, meaning gradual decline in kidney function over time despite treatment, though the rate of progression can be significantly slowed with proper care. Regular monitoring allows veterinarians to adjust treatment as the disease evolves and address new complications as they arise. Some cats achieve stable disease for extended periods before progression resumes. End-of-life planning becomes an important consideration as the disease advances, with focus shifting to comfort care and quality of life when curative treatment is no longer effective. Open communication with the veterinary team helps owners navigate these difficult decisions and ensure their cat's comfort throughout the disease journey.

Primary prevention of glomerulonephritis focuses on reducing exposure to and controlling the infectious and inflammatory conditions that commonly trigger this kidney disease. Keeping cats indoors significantly reduces exposure to feline leukemia virus, feline immunodeficiency virus, and other infectious agents associated with glomerulonephritis development. Maintaining current vaccinations according to veterinary recommendations protects against preventable diseases. Regular parasite prevention addresses both internal and external parasites that can contribute to chronic inflammation. Prompt treatment of any infections, including dental disease, skin infections, and urinary tract infections, prevents the chronic antigen stimulation that can lead to immune complex formation. For cats with known predisposing conditions, regular monitoring allows early detection of kidney involvement before significant damage occurs.

Environmental prevention strategies help reduce factors that may contribute to immune system dysfunction and disease susceptibility. Creating a low-stress home environment supports overall immune health and reduces the negative health impacts of chronic stress. In multi-cat households, ensuring adequate resources including food stations, water sources, and litter boxes helps minimize social stress. Eliminating exposure to environmental toxins, including certain houseplants, household chemicals, and medications not prescribed by a veterinarian, protects kidney health. Providing clean, fresh water encourages adequate hydration, supporting kidney function. Regular cleaning of food and water dishes reduces bacterial contamination. For outdoor cats or those with outdoor access, limiting exposure during high-risk times for infectious disease transmission may reduce risk.

Dietary prevention approaches support overall kidney health and may reduce risk factors for glomerulonephritis. Feeding high-quality commercial cat food appropriate for the cat's life stage provides balanced nutrition without excessive protein or phosphorus that can stress kidneys. Avoiding excessive treats and table food helps maintain proper nutritional balance. Ensuring cats maintain healthy body weight reduces overall metabolic stress on the kidneys. Adequate hydration, encouraged through wet food feeding, water fountains, or multiple water stations, supports kidney function. While specific dietary prevention of glomerulonephritis is not established, overall nutritional health contributes to immune system function and disease resistance. Cats with known risk factors may benefit from earlier transition to kidney-supportive diets as discussed with their veterinarian.

Regular veterinary care forms the foundation of prevention and early detection strategies. Annual wellness examinations, or more frequent visits for senior cats and those with health conditions, allow veterinarians to detect subtle changes before they become serious problems. Routine blood work and urinalysis, particularly for cats over seven years of age, can identify early kidney changes and proteinuria before clinical signs develop. Screening for infectious diseases provides important baseline information and allows early treatment when indicated. Dental cleanings reduce chronic oral infection that can trigger systemic inflammation. Blood pressure monitoring, especially in older cats, detects hypertension that can both result from and contribute to kidney disease. These preventive measures provide the best opportunity for identifying problems early when intervention is most effective.

Early intervention when risk factors or early changes are identified can significantly impact outcomes. Cats testing positive for feline leukemia virus or feline immunodeficiency virus should receive enhanced monitoring for kidney disease development. Those with chronic inflammatory conditions require regular assessment of kidney function. When routine screening reveals mild proteinuria, early treatment may prevent progression to clinical glomerulonephritis. Cats with unexplained weight loss, increased thirst, or changes in urination should be evaluated promptly rather than waiting for symptoms to worsen. Working proactively with a veterinarian to address concerning findings offers the best chance of preventing severe disease. Owner education about risk factors and early warning signs empowers early recognition and veterinary consultation, potentially preventing advanced disease that is more difficult to manage.

Daily management of a cat with glomerulonephritis requires establishing consistent routines that accommodate medication administration, dietary requirements, and monitoring needs. Most cats require at least one daily medication, typically an ACE inhibitor, administered at the same time each day. Some cats accept medications readily in pill pockets or with food, while others require more creative approaches such as compounded flavored liquids or transdermal gels. Feeding prescribed kidney diet as the primary nutrition source, divided into multiple small meals throughout the day, helps maintain appetite and reduces kidney workload. Fresh water should be available at all times, with many cats preferring running water from fountains. Daily observation of appetite, water intake, urination patterns, and general behavior helps detect changes that may indicate disease progression or complications requiring veterinary attention.

Home environment modifications support the comfort and wellbeing of cats living with glomerulonephritis. Providing multiple water stations throughout the home encourages adequate hydration. Easy access to litter boxes on each level of the home accommodates increased urination and reduced mobility that may develop over time. Comfortable resting areas with soft bedding, particularly in warm, quiet locations, support rest and recovery. Gentle climate control helps cats with decreased body condition maintain body temperature. Reducing environmental stressors such as loud noises, household conflicts, and major changes in routine supports overall health. For cats receiving subcutaneous fluids at home, creating a calm, consistent location for this procedure helps both cat and owner adapt to this routine.

Maintaining quality of life is a primary goal in managing cats with chronic glomerulonephritis, focusing on preserving the activities and interactions that bring joy. While affected cats may have reduced energy, they can still enjoy gentle play sessions, grooming, and affection from their owners. Mental stimulation through window perches for bird watching, puzzle feeders for treats, and interactive toys helps maintain cognitive engagement. Maintaining familiar routines and social interactions supports emotional wellbeing. Some cats benefit from warming beds or heated pads, especially those who have lost body condition. Quality of life assessment should be ongoing, with owners regularly evaluating their cat's happiness and comfort using standardized scales if helpful. The goal is enabling cats to continue enjoying their lives while managing their condition.

Ongoing monitoring and regular veterinary care are essential components of living with glomerulonephritis. Follow-up appointments every three to six months, or more frequently during treatment adjustments or disease progression, allow veterinarians to assess treatment response and modify the plan as needed. These visits typically include physical examination, blood pressure measurement, blood work, and urinalysis. Between veterinary visits, owners should maintain records of appetite, weight (if a home scale is available), water consumption, urination habits, and any concerning symptoms. Recognizing signs that warrant earlier veterinary consultation, including decreased appetite lasting more than a day or two, vomiting, significant lethargy, breathing changes, or sudden weakness, enables prompt intervention. Open communication with the veterinary team about observations and concerns supports optimal disease management.

Caregiver support is an often-overlooked aspect of managing a cat with chronic disease. The emotional and financial demands of caring for a cat with glomerulonephritis can be significant, and owners should not hesitate to seek support. Many veterinary practices offer payment plans or can recommend financial assistance resources. Pet health insurance, if obtained before diagnosis, may help cover ongoing costs. Online support groups connect owners facing similar challenges, providing emotional support and practical advice. Taking breaks from caregiving when possible, with trusted family members or pet sitters providing coverage, helps prevent burnout. Honest discussions with veterinarians about prognosis, quality of life, and end-of-life planning, while difficult, help owners prepare emotionally and make informed decisions. Recognizing that providing loving care for a chronically ill pet is both challenging and rewarding helps caregivers maintain perspective through the difficult times.

While glomerulonephritis can affect cats of any breed, certain breeds may face elevated risk due to predisposition to underlying conditions that trigger glomerular disease. Abyssinian cats have documented susceptibility to familial renal amyloidosis, a related condition that can present similarly to glomerulonephritis and may coexist with glomerular disease. Siamese and Oriental breeds appear in some studies as potentially having increased rates of kidney disease in general, though specific glomerulonephritis data is limited. Breeds with higher incidences of feline infectious peritonitis, a significant trigger for glomerulonephritis, may face secondary risk for developing glomerular disease following infection. Persian and Himalayan cats, while more commonly associated with polycystic kidney disease, should be monitored for various forms of kidney disease including glomerulonephritis.

Mixed breed and domestic cats constitute the majority of glomerulonephritis cases in clinical practice, reflecting both their prevalence in the general cat population and the fact that predisposing factors such as infectious diseases affect all cats regardless of breed. Cats with outdoor access face increased risk regardless of breed due to higher exposure to infectious agents. Senior cats of all breeds face increased risk as aging affects immune regulation and increases cumulative exposure to disease triggers. Male cats may be slightly overrepresented in some studies, though this finding is not consistent. Cats in multi-cat environments, particularly shelters or catteries where infectious disease transmission is more common, face elevated risk across all breeds.

Screening recommendations for at-risk cats focus on regular monitoring rather than specific genetic testing, as glomerulonephritis is not a directly inherited condition. Annual wellness examinations with blood work and urinalysis are recommended for all adult cats, with more frequent monitoring for seniors and those with known risk factors. Breeds predisposed to kidney disease should begin regular kidney function screening by middle age if not earlier. Cats testing positive for feline leukemia virus or feline immunodeficiency virus require enhanced kidney monitoring throughout their lives. Those with chronic infections or inflammatory conditions should have periodic urinalysis to detect proteinuria early. Responsible breeders should be aware of kidney disease patterns in their lines and select breeding pairs to minimize health problems, though direct genetic testing for glomerulonephritis predisposition is not currently available.

Several conditions commonly co-occur with glomerulonephritis due to shared underlying causes or as complications of glomerular disease. Chronic kidney disease often develops secondary to progressive glomerular damage and may already be present at the time of glomerulonephritis diagnosis. Hypertension (high blood pressure) affects a significant percentage of cats with glomerulonephritis and can both result from and contribute to further kidney damage. Thromboembolism, particularly arterial blood clots affecting the hind legs (saddle thrombus), represents a serious potential complication of protein-losing nephropathies including glomerulonephritis due to loss of anticoagulant proteins in urine. Anemia commonly develops as kidney disease progresses due to decreased erythropoietin production. Cats with glomerulonephritis secondary to infectious diseases may have concurrent manifestations of those infections affecting other organ systems.

Differentiating glomerulonephritis from conditions with similar clinical presentations is essential for appropriate treatment. Chronic interstitial nephritis, the most common form of chronic kidney disease in cats, can cause similar clinical signs but typically presents with less dramatic proteinuria. Renal amyloidosis, while also causing protein loss, involves deposition of abnormal amyloid protein rather than immune complexes and may require different management approaches. Tubular proteinuria results from tubular dysfunction rather than glomerular damage and typically shows different patterns on protein electrophoresis. Acute kidney injury may present with similar laboratory abnormalities but has sudden onset and often identifiable triggers such as toxin exposure or urinary obstruction. Pyelonephritis (kidney infection) causes kidney inflammation but typically shows evidence of bacterial infection and more active urine sediment.

Complications of glomerulonephritis develop as the disease progresses or as consequences of ongoing protein loss. Progressive chronic kidney disease is the most common complication, developing as ongoing glomerular damage reduces functional nephrons. Severe hypertension can lead to retinal hemorrhage or detachment, causing sudden blindness, and increases stroke risk. Arterial thromboembolism represents a life-threatening emergency occurring when protein loss includes factors that prevent blood clotting. Edema and ascites (fluid accumulation) develop when blood protein levels drop severely, causing fluid to leak from blood vessels into tissues and body cavities. Malnutrition and muscle wasting result from ongoing protein loss combined with reduced appetite and absorption. Recognizing these potential complications allows owners and veterinarians to monitor appropriately and intervene when necessary to prevent or manage these serious developments.